信件：对于初治慢性乙型肝炎患者，替诺福韦可能优于恩替卡韦——作者回复 - Suppr | 超能文献

Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients-authors' reply.

作者信息

Pol Stanislas, Lusivika Nzinga Clovis, Carrat Fabrice

机构信息

Université de Paris and Département d'Hépatologie, APHP, Hôpital Cochin, Paris, France.

INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Sorbonne Université, IPLESP, Paris, France.

出版信息

Aliment Pharmacol Ther. 2021 May;53(9):1050. doi: 10.1111/apt.16340.

DOI:10.1111/apt.16340

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients-authors' reply.信件：对于初治慢性乙型肝炎患者，替诺福韦可能优于恩替卡韦——作者回复

Aliment Pharmacol Ther. 2021 May;53(9):1050. doi: 10.1111/apt.16340.

2

Letter: tenofovir may be superior to entecavir for treatment-naïve chronic hepatitis B patients.信函：对于初治慢性乙型肝炎患者，替诺福韦可能优于恩替卡韦。

Aliment Pharmacol Ther. 2021 May;53(9):1048-1049. doi: 10.1111/apt.16323.

3

Tenofovir may be superior to entecavir for preventing hepatocellular carcinoma and mortality in individuals chronically infected with HBV: a meta-analysis.在预防慢性乙型肝炎病毒感染者的肝细胞癌和死亡方面，替诺福韦可能优于恩替卡韦：一项荟萃分析。

Gut. 2020 Oct;69(10):1900-1902. doi: 10.1136/gutjnl-2019-320326. Epub 2019 Dec 16.

4

Editorial: similar risk of hepatocellular carcinoma in chronic hepatitis B patients treated with tenofovir or entecavir-new clues from Europe. Authors' reply.社论：接受替诺福韦或恩替卡韦治疗的慢性乙型肝炎患者发生肝细胞癌的风险相似——来自欧洲的新线索。作者回复

Aliment Pharmacol Ther. 2021 Mar;53(5):659. doi: 10.1111/apt.16251.

5

Antiviral therapy after curative treatment of hepatocellular carcinoma in patients with chronic hepatitis B infection: Is tenofovir or entecavir preferred?慢性乙型肝炎感染患者肝细胞癌根治性治疗后的抗病毒治疗：替诺福韦还是恩替卡韦更优？

Eur J Intern Med. 2021 Jul;89:27-29. doi: 10.1016/j.ejim.2021.05.003. Epub 2021 May 20.

6

Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B.替诺福韦与恩替卡韦预防慢性乙型肝炎患者肝细胞癌及死亡的比较

Gut. 2020 Nov;69(11):2054-2056. doi: 10.1136/gutjnl-2019-320554. Epub 2020 Feb 10.

7

A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naïve chronic hepatitis B in South Korea.韩国一项恩替卡韦与替诺福韦治疗初治慢性乙型肝炎预后的多中心研究。

J Hepatol. 2019 Sep;71(3):456-464. doi: 10.1016/j.jhep.2019.03.028. Epub 2019 Apr 6.

8

Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy-Author's reply.信件：恩替卡韦与替诺福韦对根治性肝切除术后乙型肝炎病毒相关性肝细胞癌患者血清脂蛋白水平的影响——作者回复

Aliment Pharmacol Ther. 2023 Oct;58(8):845-846. doi: 10.1111/apt.17693.

9

Letter: is tenofovir superior to entecavir for hepatocellular carcinoma prevention in chronic hepatitis B? Authors' reply.信件：在慢性乙型肝炎中，替诺福韦在预防肝细胞癌方面是否优于恩替卡韦？作者回复。

Aliment Pharmacol Ther. 2020 Jan;51(2):315-316. doi: 10.1111/apt.15614.

10

Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy.信函：恩替卡韦与替诺福韦对根治性肝切除术后乙型肝炎病毒相关肝细胞癌患者血清脂蛋白水平的影响

Aliment Pharmacol Ther. 2023 Oct;58(8):842-844. doi: 10.1111/apt.17668.

引用本文的文献

1

Effect of Entecavir Combined with Adefovir Dipivoxil on Clinical Efficacy and TNF- and IL-6 Levels in Patients with Hepatitis B Cirrhosis.恩替卡韦联合阿德福韦酯对乙型肝炎肝硬化患者临床疗效及肿瘤坏死因子和白细胞介素-6水平的影响

J Oncol. 2021 Aug 24;2021:9162346. doi: 10.1155/2021/9162346. eCollection 2021.